NOS3 and endothelial dysfunction: Peng Li et al. (2016) carried out several analyses in vitro and vivo models suggesting that the miR-133a may be a relevant trigger for statin in order to prevent eNOS decoupling, paving the way for possible endothelial dysfunction therapy through oxidative stress modulation [115].